A scoping review of paediatric latent tuberculosis infection care cascades: initial steps are lacking

Jeffrey I Campbell1, Thomas J Sandora2, Jessica E Haberer3

  • 1Division of Infectious Diseases, Department of Pediatrics, Boston Children's Hospital, Boston, Massachusetts, USA Jeffrey.Campbell@childrens.harvard.edu.

BMJ Global Health
|May 21, 2021
PubMed

Insights

Identifying and treating latent tuberculosis infection in children is crucial. This review highlights gaps in understanding the pediatric TB infection care cascade, emphasizing the need for research on early steps and health system factors.

Area of Science:

  • Public Health
  • Infectious Disease Epidemiology
  • Pediatric Healthcare

Background:

  • Latent tuberculosis infection (TB infection) identification and treatment in children is vital for preventing TB disease and global TB elimination.
  • The TB infection care cascade outlines the necessary steps for diagnosis and treatment.
  • A comprehensive literature summary on the pediatric TB infection care cascade was lacking.

Purpose of the Study:

  • To conduct a scoping review of the pediatric TB infection care cascade.
  • To identify facilitators and barriers to retention within the cascade.
  • To explore interventions for mitigating attrition and address knowledge gaps.

Main Methods:

  • Systematic search of PubMed, CINAHL, Cochrane, and Embase databases.
  • Inclusion of articles and abstracts on children and adolescents (≤21 years) screened for or diagnosed with TB infection.
  • Synthesis of studies to identify cascade step completion, attrition factors, and interventions.

Main Results:

  • 146 studies were identified, with 31 focusing on low- and middle-income countries.
  • Most literature concentrated on treatment initiation to completion.
  • Patient and caregiver factors were frequently cited, while health system factors and interventions were less explored.

Conclusions:

  • Gaps exist in the literature, particularly in cascade steps before treatment initiation.
  • Future research should focus on identifying and testing at-risk pediatric patients.
  • Emphasis on modifiable health system factors and implementation science is recommended to improve retention.
Abstract

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
287
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
251
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
784
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
446
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
563
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.6K